Remimazolam is a novel general anesthetic drug. The time to emergence from remimazolam-based general anesthesia is variable among patients, but little is known about the risk factors for delayed emergence. We believe that information from body composition analysis may be helpful in understanding which patients are more likely to show delayed emergence from remimazolam.
Study Type
OBSERVATIONAL
Enrollment
90
Body composition analysis by bioelectrical impedance measurement, just before induction of anesthesia.
Samsung Medical Center, Sungkyunkwan University, School of Medicine
Seoul, South Korea
emergence time
relationship between body composition analysis information and time to emergence after discontinuing remimazolam infusion.
Time frame: at the time of emergence
time to loss of consciousness
relationship between body composition analysis information and time to loss of consciousness after starting remimazolam infusion.
Time frame: at the time of induction
hypotension
relationship between body composition analysis information and hypotensive event during anesthesia
Time frame: from induction to emergence of anesthesia
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.